Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

1.11
+0.06005.71%
Volume:30.96K
Turnover:33.40K
Market Cap:6.85M
PE:-0.58
High:1.11
Open:1.06
Low:1.05
Close:1.05
Loading ...
Apr 05, 2021

Major Issues Report

8-K - Current report
Mar 26, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 22, 2021

Major Issues Report

8-K - Current report
Mar 22, 2021

Major Issues Report

8-K - Current report
Mar 22, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 25, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 17, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 15, 2020

Major Issues Report

8-K - Current report